Pegylated Interferon Alpha 2B 150mcg
You Searched


WHO GMP
Certified

Long Expiry
(>8 Months)

WHO GMP
Certified

Long Expiry
(>8 Months)
In Chronic hepatitis C virus (HCV) infection Viraferonpeg 150mcg Injection helps control the infection and makes the immune system work better. This lowers your chances of getting complications and improves your quality of life. This medicine is always taken in combination with other antiretroviral medicines. It is not a cure and should neither be used to prevent HCV infection. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of the medicine.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Viraferonpeg 150mcg Injection modulates the body's immune system.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Viraferonpeg 150mcg Injection .
Seek medical advice from your doctor: Viraferonpeg 150mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Viraferonpeg 150mcg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not Safe: Viraferonpeg 150mcg Injection may cause side effects which could affect your ability to drive. Patients may develop dizziness, confusion, somnolence, and fatigue while on Viraferonpeg 150mcg Injection and should be cautioned to avoid driving.
Not Safe: Viraferonpeg 150mcg Injection is probably unsafe to use in patients with kidney disease and should be avoided. Doctor consultation is advised. Caution should be used in patients with renal impairment.
Seek medical advice from your doctor: There is limited information available on the use of Viraferonpeg 150mcg Injection in patients with liver disease. Doctor consultation is advised.
If a dose of Viraferonpeg 150mcg Injection is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Platina, 8th Floor, C.59, G Block, Bandra Kurla Complex, Bandra (East) , Mumbai - 400098,
Peginterferon alfa-2b. Kenilworth, New Jersey: Schering Corporation; 2011 (25 Jun. 2019)
Medscape. Peginterferon alfa 2b (26 Jun. 2019)
MedlinePlus. Peginterferon Alfa-2b (26 Jun. 2019)
Drugs and Lactation Database (LactMed) (18 Feb. 2020)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.